Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II, Randomized, Observer Blind, Multi-Center, Active Controlled Study to Evaluate the Safety and Immunogenicity of Novartis Meningococcal ACWY Conjugate Vaccine in Healthy Children Aged 12-59 Months.

NCT00310817 is registered in ClinicalTrials.gov with Novartis Vaccines as lead sponsor.

NCT NCT00310817
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00310817 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II, Randomized, Observer Blind, Multi-Center, Active Controlled Study to Evaluate the Safety and Immunogenicity of Novartis Meningococcal ACWY Conjugate Vaccine in Healthy Children Aged 12-59 Months.
Lead sponsor
Novartis Vaccines
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2005
Completion date
May 31, 2006
Enrollment
623 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

meningococcal meningitis